Anti-oncogene Ribozymes for Cancer Gene Therapy
- 1 January 1997
- book chapter
- Published by Elsevier
- Vol. 40, 207-257
- https://doi.org/10.1016/s1054-3589(08)60141-6
Abstract
No abstract availableThis publication has 266 references indexed in Scilit:
- Ribozymes Cleave the AML1/MTG8 Fusion Transcript and Inhibit Proliferation of Leukemic Cells with t (8;21)Biochemical and Biophysical Research Communications, 1995
- Replicating vectors for gene therapy of cancer: risks, limitations and prospectsEuropean Journal Of Cancer, 1994
- Versatile adeno-associated virus 2-based vectors for constructing recombinant virionsGene, 1993
- Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras geneGene, 1992
- Cisplatin resistance in human cancersPharmacology & Therapeutics, 1991
- Two sequences participating in the autolytic processing of satellite tobacco ringspot virus comple- mentary RNAGene, 1989
- Sequences required for self-catalysed cleavage of the satellite RNA of tobacco ringspot virusGene, 1989
- RNA mediated formation of a phosphorothioate diester bondBiochemical and Biophysical Research Communications, 1988
- Adriamycin resistance in HL60 cells in the absence of detectable P-glycoproteinBiochemical and Biophysical Research Communications, 1987
- Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNAGene, 1983